12 July 2022

Michiel Vermeulen, professor of Molecular Biology at the Radboud University, has been elected as one of the new members of the EMBO. EMBO is an organisation of more than 1,800 leading researchers that promotes excellence in the life sciences in Europe and beyond. The major goals of the organisation are to support talented researchers at all stages of their careers, stimulate the exchange of scientific information, and help build a research environment where scientists can achieve their best work.

“The new EMBO Members and Associate Members are exceptional scientists, who carry out leading research across a variety of fields, ranging from cell biology and cancer to vaccine development and machine learning,” says EMBO Director Fiona Watt.

Members provide guidance and support for EMBO activities, for example by evaluating funding applications, serving on EMBO Council and committees, or joining the editorial boards of EMBO Press journals. Through their involvement, members help shape the direction of life sciences, foster the careers of young researchers, and strengthen the research communities in Europe and beyond.

The lab of Michiel Vermeulen uses integrative omics approaches to study gene expression regulation in health and disease. Michiel Vermeulen: 'I am very honored and excited to become part of the vibrant EMBO community, whose goal is to promote and support excellence in the life sciences in Europe and beyond. I very much look forward to contribute to this mission.'

EMBO will formally welcome the new members at the annual Members’ Meeting in Heidelberg between 26 and 28 October 2022.

More information

Related news items


Joint research in regional hospitals New research projects from promotion fund

22 November 2022

Four research projects have been honored in the promotion fund of the Radboudumc and four regional hospitals. The research projects, which are a collaboration between CWZ, Jeroen Bosch Hospital, Rijnstate, Sint Maartenskliniek and the Radboudumc will receive a contribution of 240,000 euros.

read more

Trained immunity’s role in kidney disease

17 November 2022

Researcher(s) Jordi Ochando of the Icahn School of Medicine at Mount Sinai in New York and Raphaël Duivenvoorden of the Department of Nephrology at Radboudumc explain how trained immunity can have detrimental effects in kidney disease and transplantation. 

read more